(Q41884506)

13 October 2017

Understanding the structure and stability of paclitaxel nanocrystals (English)

1 reference

13 October 2017

1 reference

Jiexin Deng

1

1 reference

13 October 2017

Leaf Huang

series ordinal

2

1 reference

13 October 2017

Feng Liu

series ordinal

3

1 reference

13 October 2017

language of work or name

English

0 references

publication date

16 February 2010

1 reference

International Journal of Pharmaceutics

13 October 2017

1 reference

13 October 2017

390

1 reference

13 October 2017

2

1 reference

13 October 2017

242-249

1 reference

Targeted cancer therapy with novel high drug-loading nanocrystals

13 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3685190

Top-down production of drug nanocrystals: nanosuspension stabilization, miniaturization and transformation into solid products.

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3685190

Preparation and evaluation of nanosuspensions for enhancing the dissolution of poorly soluble drugs

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3685190

Nanosuspensions in drug delivery

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3685190

Polymeric micelles of poly(2-ethyl-2-oxazoline)-block-poly(ε-caprolactone) copolymer as a carrier for paclitaxel

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3685190

Production and characterization of a budesonide nanosuspension for pulmonary administration

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3685190

Paclitaxel and its formulations

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3685190

In vivo evaluation of polymeric micellar paclitaxel formulation: toxicity and efficacy

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3685190

Preparation of a clofazimine nanosuspension for intravenous use and evaluation of its therapeutic efficacy in murine Mycobacterium avium infection

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3685190

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3685190

In vitro and in vivo antitumor activity of oridonin nanosuspension.

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3685190

Formulation and pharmacokinetic evaluation of an asulacrine nanocrystalline suspension for intravenous delivery

18 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3685190

Drying of crystalline drug nanosuspensions-the importance of surface hydrophobicity on dissolution behavior upon redispersion

18 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3685190

The effects of Pluronic block copolymers on the aggregation state of nystatin

18 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3685190

Eudragit RS100 nanosuspensions for the ophthalmic controlled delivery of ibuprofen

18 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3685190

Lab-scale production unit design for nanosuspensions of sparingly soluble cytotoxic drugs.

18 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3685190

Formulation and antitumor activity evaluation of nanocrystalline suspensions of poorly soluble anticancer drugs

18 August 2018

1 reference

12 December 2020

Histamine release by contrast media

1 reference

12 December 2020

Physical stability of ethyl diatrizoate nanocrystalline suspension in steam sterilization

1 reference

12 December 2020

Nanosuspensions as a new approach for the formulation for the poorly soluble drug tarazepide

1 reference

12 December 2020

10.1016/J.IJPHARM.2010.02.013

Identifiers

DOI

1 reference

13 October 2017

1 reference

13 October 2017

PubMed publication ID

20167270

1 reference